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Abstract 
Enzymes exhibit a large degree of compatibility with metal-organic frameworks (MOFs) that 
allow to develop multicomponent catalysts constituted by enzymes adsorbed or occluded by MOFs. 
The combination of enzymes and MOFs in a multicomponent catalyst can be used to promote cascade 
reactions in which two or more individual reaction are performed in a single step. The cascade reactions 
take place due to the cooperation of active sites present on the MOF with the enzyme. Survey of the 
available data establishes that often the enzyme undergoes stabilization by association with MOF and 
the system exhibits a notable recyclability. In addition, the existence of a synergism is observed as 
consequence of the close proximity of all the required active sites in the multicomponent catalyst. After 
an introductory section describing the specific features and properties of enzyme-MOF assemblies, the 
main part of the present review focuses on the description of the cascade reactions that have been 
reported with commercial enzymes associated with MOFs, paying special attention to the advantages 
derived from the multicomponent catalyst. Related with the catalytic activity to metabolize glucose, 
generating reactive oxygen species and decreasing the solution pH, an independent section describes 
the recent use of enzyme-MOF catalysts in cancer therapy. The last paragraphs summarize the current 
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Enzymes are the most efficient and selective catalysts working under mild, physiological 
conditions.1 The use of enzymes to synthesise organic molecules, particularly for the commercial 
production of complex multifunctional compounds of interest as pharmaceuticals has been growing 
continuously. Under metabolic conditions, transformation of biomolecules requires the cooperative 
contribution of several enzymatic systems, resulting in the occurrence of various individual reactions in 
which the product of one transformation is the substrate for the subsequent process.2-4 These types of 
consecutive reactions, combining in a single step two or more different reactions, are generally known 
as cascade or tandem reactions and they represent an example of process intensification.5-7 Cascade 
reactions minimize tedious reaction work-up and make unnecessary isolation of intermediate 
compounds in a synthetic route.  
The complexity of biochemical cycles involving several enzymatic systems makes difficult to 
mimic the cascade processes occurring in the synthesis of biomolecules in a non-natural environment. 
However, a step forward is to couple enzymatic activity with conventional acid/base or redox catalysis 
due to transition metal sites.8, 9 Particularly interesting is when heterogeneous solid catalysts are 
combined with enzymes that remain adsorbed or occluded within the solid, since in this way, the 
enzyme can become immobilized and can be easily separated from the reaction mixture and recycled.10-
12 
While enzymes have been attached to a large variety of carbon materials or high surface area 
metal oxides, there is a growing interest in the use of MOFs as supports and complementary catalysts 
for enzymes.13, 14 The main reason for this interest is the synergy that has been often observed for this 
type of multicomponent MOF catalysts compared to alternative supports. 
MOFs are porous crystalline coordination polymers whose structure is constituted by nodes of 
metal ions or clusters of metal ions in strong interaction through Coulombic and coordinative bonds with 
rigid multipodal organic ligands.15-17 The defined directionality of coordinative bonds around the metal 
nodes and the geometry of the binding sites of the organic ligand determine a low density of the unit 
cell that has an open porosity in the range of micro- and mesoporosity. MOFs are materials with a very 
large surface area and pore volume.18-21 The reader is referred to the existing literature for an in-depth 
description of the synthesis, structures, physical properties and applications of MOFs, including their 
use as heterogeneous catalysts.10, 11, 22-25 
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In the literature there are basically three possible strategies to obtain the enzyme-MOF 
composite (Chart 1). One of them requires MOFs of pore sizes larger than the enzyme dimension.11, 26, 
27 Enzymes have a wide range of molecular weight and sizes, but many of them have dimensions in 
the mesoporous scale between 3 to 6 nm. Thus, for certain large-pore MOFs it could be possible to 
incorporate enzymes within their mesopores. However, large pore MOFs tend to be remarkably instable 
and this strategy is limited to only a few MOF structures. 
 
Chart 1. Most commonly employed strategies for the preparation of MOFs-enzyme composite. 
The most common and robust MOFs have pore sizes about 1-2 nm, therefore, too small to 
accommodate enzymes within their voids. However, even in these cases, MOFs crystallites can be 
formed around the enzyme that becomes the core of the material surrounded by a dense layer of MOF 
particles.11, 25, 28 The inner enzyme will still be accessible to substrates due to MOF porosity. The 
requisite in this strategy is the compatibility of MOF synthesis with enzyme stability. This limits the range 
of MOFs that can be used to those whose synthesis is mainly a precipitation of the metal ions by the 
ligands, without the need of lengthy hydrothermal treatment in organic solvents at high temperatures. 
In this strategy the functional groups of the enzyme can adsorb metal ions, initiating the nucleation of 
the MOF. 
In a third strategy, enzyme becomes adsorbed onto the external surface of MOF microcrystals. 
In some cases, the enzyme-MOF association is strong since it is due to Coulombic interactions due to 
complementary surface charges of both components.9, 11 
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Besides, design capability and large compositional and structural diversity, one advantage of 
using MOFs as support for enzymes are the presence of active sites. Active sites in MOFs can be due 
to i) the presence of Lewis acid sites in exchangeable coordination positions around the transition 
metals, ii) substituents on the organic ligands, iii) the presence of structural defects, and iv) the presence 
of active guests within the pores, such as metal nanoparticles (NPs) or metal complexes. As it will be 
shown in the following sections, this range of possibilities can be combined with the enzymatic activity, 
developing stable, recyclable, enzyme-MOF catalysts for cascade reactions.  
For obvious reasons of availability, the current existing literature on enzyme-MOF catalysts for 
cascade reactions is mostly limited to commercially available enzymes, such as lipases and oxidases. 
However, it will be emphasised in the sequel that there are sufficient number of examples showing the 
enzymes are largely compatible with the composition and structure of MOFs. Even more, there is 
evidence showing that the enzyme becomes stabilized and its activity maintained as consequence of 
its immobilization within/on MOFs. In addition, examples of synergy between the two components as 
consequence of their association and close proximity has been also frequently observed by comparing 
the activity of the multicomponent enzyme-MOF catalyst compared to their independent components.11 
It appears that the close spatial proximity among the various active sites involved in the cascade 
process favours a faster diffusion of the intermediates, resulting in a faster reaction and, consequently, 
in a higher selectivity derived from the formation of by-products in a lesser percentage. 
The main part of the review describes relevant examples of the catalytic activity of enzyme-
MOF catalyst in cascade reaction for the production of chemicals or for reaction with biomolecules not 
only for the synthesis of products by also for sensing application. Those reports describing the 
cooperation of more than one enzyme will also be described. In a separate section the possibility to use 
enzyme-MOF systems for cancer therapy by causing tumoral cell death by starvation and over 
production of reactive oxygen species will also presented. The last section of the review will summarize 
the main points of the current state of the art and will provide our prospects for future development of 
the field. 
2. Enzymes@MOFs for cascade catalysis 
One long standing goal in the development of multifunctional solid catalysts is the rational 
engineering and assembly of diverse active centres in a highly structured material to achieve high 
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reactivity and selectivity. In this respect, ultra-large mesopores (20-40 nm) MOF crystals have been 
prepared by competitive coordination chemistry with polyvinylpyrrolidone (PVP), allowing the 
incorporation of large guests, like enzymes whose dimensions are tens of nm. The resulting composite 
integrates different catalytic sites such as Lewis acids through coordinatively unsaturated metal sites of 
the nodes, possible occluded metal nanocrystals (NCs) and enzymes in a single MOF solid (Figure 1).29  
In one example of this strategy, a porous, defect-rich ZIF-67 (DP-ZIF67) (ZIF: Zeolitic 
Imidazolate Framework) was obtained employing PVP as metal coordinating bulky polymer during the 
crystallization of ZIF-67. The presence of PVP induces partial disruption of imidazole-Co(II) catenation, 
resulting in the generation of defects, and, simultaneously, creates high mesoporosity in DP-ZIF67 
crystals. Interestingly, transmission electron microscopy (TEM) images revealed that DP-ZIF67 has 
identical rhombic dodecahedron morphology as pristine ZIF-67 with particles ca. 800 nm size. 
Brunauer-Emmett-Teller (BET) surface area measurements indicated DP-ZIF67 and ZIF-67 exhibit 
1654 and 1672 m2g-1, respectively. X-Ray photoelectron spectroscopy (XPS) analysis revealed a two-
fold increase in the density of unsaturated Co sites from 7.8% for ZIF-67 to 18.3% for DP-ZIF67. Pd 
NCs were loaded on DP-ZIF67 to obtain Pd@DP-ZIF67, which was further incubated with Candida 
antarctica lipase A (CalA) to provide solid Pd@DP-ZIF67/CalA integrating the enzyme. CalA is an 
enzyme able to promote enantioselective esterification, particularly acetylations using enol acetates as 
reagents. The loading of enzyme in the final solid was 26.5% as evidenced by the colorimetric Bradford 
assay. The Fourier-transform infrared (FT-IR) spectrum of Pd@DP-ZIF67/CalA exhibited C=O 
stretching vibration at 1660 cm-1 corresponding to amide-I of the enzyme, in addition to other 
characteristic peaks for ZIF-67.  
The catalytic efficiency of Pd@DP-ZIF67/CalA was assessed in the cascade reaction involving 
the nitroaldol reaction promoted by the Lewis acid sites, Pd-NCs as racemisation catalyst and CalA for 
enzymatic kinetic resolution and acylation. Under the optimized reaction conditions, the reaction 
between p-anisaldehyde and nitromethane in N,N-diisopropylethylamine and vinylacetate as the acyl 
donor using Pd@DP-ZIF67/CalA at room temperature  afforded the desired chiral acetylated 
nitroalcohol with >97% conversion and >99% enantiomeric excess (>99% ee) (Figure 2a). In contrast, 
a series of control experiments with a mixture of Co(NO3)2·6H2O and imidazole as well as ZIF-67 
showed very poor activities compared to the DP-ZIF67 (Figure 2b). On other hand, DP-ZIF67 pre-
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treated with excess 2-methylimidazole (2-MeIm) exhibited poor yield of the nitroaldol product due to the 
poisoning of unsaturated Co(II) sites by saturation, indicating the effective role of Lewis acid sites. Lower 
activities in the formation of the nitro acetate product were also attained for the physical mixture of DP-
ZIF67, Pd NCs and CalA  (ca. 20% ee) as well as the physical mixture of Pd@DP-ZIF67 and CalA@DP-
ZIF67 (ca. 38% ee). In another control experiment, the physical mixture of Pd@DP-ZIF67 and free CalA 
was employed as catalysts under identical conditions, observing only ca. 24% ee of the product. These 
control experiments clearly show the superior performance of the integrated Pd@DP-ZIF67/CalA solid 
catalyst, indicating clearly the effect of immobilization of CalA within the mesopores of MOFs not only 
by increasing the stability, but reaching higher activity through the confinement effect due to the close 
intimacy between the active sites.  
Pd@DP-ZIF67/CalA was facilely recovered and reused in five successive cycles with 86% yield 
and >80% ee of product. Further, TEM, high resolution transmission electron microscopy (HRTEM) and 
energy dispersive spectroscopy (EDS) mapping analyses indicated that no significant change in the 
particle morphology, Pd NC particle size and CalA loading takes place in five cycles. However, the slight 
decrease in the activity was due to Pd leaching as evidenced by inductively coupled plasma (ICP) 
analysis. Interestingly, Pd@DP-ZIF67/CalA exhibited very high yields (>99%) and ee (>99%) of various 
nitro acetates from different aryl aldehydes irrespective of the electron donating or withdrawing nature 
of the substituents. 
 
Figure 1. Synthetic strategy towards multimodal catalytic nanoreactors (MCNRs) containing 
coordinatively unsaturated Co2+ (violet colored metal sites), Pd NCs and CalA inside DP-ZIF67. 
Reproduced with permission from ref.29 Wiley, Copyright 2020. 
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Figure 2. (a) Schematic illustration of the cascade reaction catalyzed by Pd@DP-ZIF67/CalA, (b) 
Kinetics of nitrolaldol reaction catalyzed by DP-ZIF67 and various control catalysts. (c) The Pd@DP-
ZIF67/CalA and various control catalysts catalyzed cascade catalysis to obtain enantiomerically pure 
β-nitroacetate, in high yield showing that co-immobilization of the active sites has a positive effect on 
the product ee and product yield. (d) Reaction yield, ee values and time in five cycles for the conversion 
of p-anisaldehyde to β-nitroacetate using Pd@DP-ZIF67/CalA as catalyst. Reproduced with permission 
from ref 29 Wiley, Copyright 2020. 
An amino functionalized UiO-66 MOF (UiO-66-NH2) was subjected to ligand exchange by lauric 
acid (LA) to obtain a sample denoted as UiO-LA, which was further used as a robust host for the 
stepwise immobilization of Pd (NPs) and Candida antarctica lipase B (CalB) to obtain a multicomponent 
catalyst (CalB-Pd@UiO-LA; Figure 3). The catalytic activity of this solid was tested in the synthesis of 
benzyl hexanoate from benzaldehyde and ethyl hexanoate through cascade reactions.30 The average 
diameter of Pd NPs was around 3.41±0.49 nm. Among the various catalysts screened, CalB-Pd@UiO-
LA50 solid afforded 100% yield of benzyl hexanoate after 8 h, while either CalB-Pd@UiO or CalB-
Pd@UiO-LA20 provided 76% yield under identical conditions (Scheme 1). The superior performance 
of CalB-Pd@UiO-LA50 was ascribed to its improved dispersability in the reaction medium thus 
facilitating the interaction of substrates with the active sites. In contrast, the activity of the physical 
mixture of Pd@UiO-LA50 and free CalB was lower than CalB-Pd@UiO-LA50, a result that was 
attributed to the aggregation of free CalB. The yield of benzyl hexanoate was retained at about 80 % 
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after three cycles. This minor decrease in the activity is due to Pd leaching, while no obvious leaching 
of CalB was observed as assessed by Bradford test. 
 
Figure 3. Synthesis of CalB-Pd@UiO-LA20 and CalB-Pd@UiO-LA50. Reproduced with permission 
from ref.30 Wiley, Copyright 2019. 
 
Scheme 1. Synthesis of benzyl hexanoate from benzaldehyde through cascade catalysis by CalB-
Pd@UiO-LA50. 
3. Enzymes@MOFs for cascade biocatalysis 
3. 1 Encapsulation of mono enzymes 
Another commercially available enzyme that has been widely used in combination with MOFs 
is glucose oxidade (GOx) that catalyzes the selective aerobic oxidation in aqueous media of glucose to 
gluconic acid. A self-activated MOF/enzyme hybrid nanoreactor (MIL@GOx-MIL NRs) was fabricated 
by employing MIL-101(Fe)-NH2 NPs and GOx through a two-step procedure (Figure 4).31 In this catalytic 
system, GOx is responsible for the conversion of glucose to gluconic acid, a conversion that lowers the 
pH from 7.4 to around 4. Further, MIL@GOx-MIL NRs afforded the highest performance in hydroxyl 
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radical generation from H2O2 at pH 4 than at pH 7.4. Therefore formation of gluconic acid activates the 
efficient generation of hydroxyl radicals.  
Furthermore, MIL@GOx-MIL NRs exhibits an interesting antibacterial activity. This biocide 
activity was studied by a standard plate counting assay, whereby it was observed that the growth of 
methicillin-resistant staphylococcus aureus (MRSA) is effectively limited at 5 µg/mL of MIL@GOx-MIL 
NRs. On other hand, nearly no MRSA biofilms were seen at a dosage of 80 µg/mL of MIL@GOxMIL 
NRs. Therefore, these results clearly illustrate the effective role of self-activated cascade catalysis in 
the field of combating drug-resistant bacteria and related disinfection of other pathogens. 
 
Figure 4. The fabrication of self-activated MOF/enzyme hybrid NRs based on MIL NPs and GOx and 
the mechanism on combating MRSA. Reproduced with permission from ref.31 Elsevier, Copyright 2020. 
An amino functionalized Fe-MOF (Fe-MIL-88B-NH2) was employed as support for the 
immobilization of GOx assisted by cross-linking agents and the resulting composite (Fe-MOF-GOx) 
activity was examined in the cascade reaction involving oxidation of glucose followed by 3,3′,5,5′-
tetramethylbenzidine (TMB) (Figure 5).32 The experimental results have shown that Fe-MOF-GOx 
exhibited 1.4 fold increased absorbance than the physical mixture of Fe-MOF and GOx under identical 
conditions. This enhanced activity of Fe-MOF-GOx is ascribed to the confinement of reactants within 
the nanometric reactors diminishing diffusion limitations and minimizing the decomposition of H2O2 
generated from the GOx-catalyzed oxidation of glucose with O2. Furthermore, the catalytic activity of 
Fe-MOF-GOx was retained for five cycles, while the activity of Fe-MOF/GOx decreased sharply under 
identical conditions (Figure 6).  
- 10 - 
 
 
Figure 5. (a) Illustration of the synthetic approach of Fe-MOF-GOx and (b) corresponding cascade 
catalytic detection of glucose by Fe-MOF-GOx. Reproduced with permission from ref.32 American 
Chemical Society, Copyright 2019. 
 
Figure 6. Relative catalytic activity of Fe-MOF/GOx and Fe-MOF-GOx in five successive cycles. 
Reproduced with permission from ref.32 American Chemical Society, Copyright 2019. 
Later, PCN-222(Fe) (PCN: Porous Coordination Network) MOF was assembled by the reaction 
of highly stable Zr6 clusters with TCPP(Fe) (TCPP: tetrakis(4-carboxyphenyl)-porphyrin). Further, PCN-
222(Fe) exhibited strong electrostatic interaction with GOx which favoured negligible enzyme leaching. 
Hence, a facile strategy was reported for the immobilization of GOx on PCN-222(Fe) to obtain 
[GOx/PCN-222(Fe)] through Coulombic interactions in which PCN-222(Fe) serves as both a support 
and chemocatalyst (Figure 7). The cascade catalytic activity of GOx/PCN-222(Fe) was tested in the 
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glucose oxidation and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid (ABTS) or pyrogallol 
oxidation (Scheme 2).33 The kinetic experiments have clearly shown that the Michaelis constant (Km) 
for the oxidation of pyrogallol (0.72) is lower than that of ABTS oxidation (1.25). These catalytic data 
suggest that GOx shows higher affinity for pyrogallol due to its smaller size and easier diffusion inside 
the pores compared to bulkier ABTS. Furthermore, GOx/PCN-222(Fe) displayed identical conversion 
rate in six repeated cycles, thus showing the stability of this catalyst under these experimental 
conditions.  
 
Figure 7. Immobilization of GOx on PCN-22(Fe) and cascade reaction involving glucose aerobic 
oxidation with generation of H2O2 and subsequent generation of ABTS radical cation. Reproduced with 
permission from ref.33 American Chemical Society, Copyright 2019. 
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Scheme 2. Oxidation of pyrogallol and ABTS by GOx/PCN-222(Fe) by coupling H2O2 generation and 
enzymatic glucose oxidation. 
In another work, the peroxidase-like activity of hierarchically porous MOF, HP-PCN-224(Fe) 
allowed the design of a cascade catalyst by immobilizing GOx over HP-PCN-224(Fe) to obtain 
GOx@HP-PCN-224(Fe) (Figure 8).34 Among the various experimental conditions tested, in more acidic 
or alkaline conditions, GOx@HP-PCN-224(Fe) exhibited superior activity compared to free GOx. 
Further, GOx@HP-PCN-224(Fe) maintained about 90 % residual activity after five cycles, showing 
excellent stability under these conditions.  
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Figure 8. Schematic diagram of the preparation of the mimic multi-enzyme system enzyme@HP-PCN-
224(Fe): (a) the 6-connected D3d symmetric Zr6 and (b) tetratopic TCPP ligand in PCN-224(Fe). (c) 
Crystal structure of PCN-224(Fe). (d) Schematic of the parent PCN-224(Fe). (e) The synthesis of 
hierarchically porous PCN-224(Fe) with a modulator/surfactant-induced strategy, (f) the activation of 
hierarchically porous PCN-224(Fe), and (g) the mimic multi-enzyme systems. Reproduced with 
permission from ref.34 American Chemical Society, Copyright 2018. 
In related study, a mimic multi-enzyme system was fabricated by immobilizing GOx within the 
pores of MOF-545(Fe) and the activity of the resulting enzymatic system (Figure 9) was evaluated in 
the cascade catalysis of the aerobic oxidation of glucose and ABTS radical cation generation.35 The 
visual observation of ABTS+· radical cation allows to apply the system as a glucose sensor. Thus, 
GOx@MOF-545(Fe) can serve for a rapid detection of glucose with a low limit of detection (0.28 μM) 
and high specificity. Furthermore, GOx@MOF-545(Fe) retained 92% of its original activity after stored 
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for seven days, while only 40% of activity of free enzyme was maintained under analogous conditions. 
On other hand, GOx@MOF-545(Fe) was used for five cycles by maintaining 71% of its initial activity. 
 
Figure 9. Schematic illustration of the preparation of GOx@MOF-545(Fe) composites through 
electrostatic surface adsorption. Reproduced with permission from ref.35 Elsevier, Copyright 2020. 
3.2 Encapsulation of dual enzymes 
Cascade reactions involving enzyme as one of the active sites have received considerable 
attention due to the exquisite substrate selectivity of the enzyme that makes possible to perform 
concurrent chemical reactions with high activity and selectivity.36 In this context, a so-called amino acid-
boosted one pot embedding (AAOPE) strategy was developed for the encapsulation of a broad range 
of proteins or enzymes within the pores of MOFs.37 The inspiration for the development of this strategy 
stemmed from the metal cations-accumulating pattern of the metallothioneins (Figure 10A)38 Hence, 
the proteins assembled with abundant cysteine (Cys) favoured the accumulation of Zn2+ ions by 
mercaptide bonds, and thus accelerated the formation of prenucleated clusters, allowing the fabrication 
of MOFs around the proteins (Figure 10B). One unique example of the AAOPE strategy is the 
preparation of multi-enzymes-coencapsulated ZIF-8 that act as enzyme cascade nanoreactors (ECN, 
Figure 11A).39 The coencapsulation of two enzymes, namely, horseradish peroxidise (HRP) and GOx 
was achieved using AAOPE strategy. Characterization by confocal microscopy clearly proved both HRP 
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and GOx are homogenously distributed within ZIF-8 MOF (Figure 11B), which is favourable for 
biocatalytic cascade reactions. Interestingly, ECN showed around three-fold enhancement in the 
cascade activity in the formation of glucose than the bulk mixture of the free enzymes in solution (Figure 
11C). This enhanced activity of ECN was due to the high population of the substrates at the 
intercommunicated enzymes in ECN. In addition, ECN was also found to exhibit superior activity for 
glucose sensing with naked eyes (Figure 11D) than other reported colorimetric glucose sensors.40-44 
 
Figure 10. (A) Schematic representation of the Zn2+-binding metallothionein; (B) Schematic 
representation of the amino acid-boosted one pot embedding strategy. Reproduced with permission 
from ref.37 Wiley, Copyright 2019. 
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Figure 11. (A) Schematic representation of two-enzyme cascade nanoreactor for catalysis. (B) Confocal 
microscopy image of the HRP and GOx within ZIF-8; Rhodamine B-labelled HRP at 543 nm excitation 
wavelength (i); Fluorescein thioisocyanate-labelled GOx at 488 nm excitation wavelength (ii); a merged 
image of the other two images (iii). (C) Monitoring the catalytic product of glucose yielded form ECN 
versus the free enzymes system by UV absorbance at 450 nm. (D) Linear range of the visual glucose 
sensing. Reproduced with permission from ref.37 Wiley, Copyright 2019. 
Recently, HRP and GOx enzymes were cross-linked by rationally designed DNA and later, the 
multienzyme system was encapsulated into ZIF-8 to obtain GOx&HRP@DNA/ZIF-8. The activity of this 
enzymatic complex was tested in the oxidation of glucose followed by ABTS (Figure 12).45 Under the 
optimized reaction conditions, the cascade activity of GOx&HRP@DNA/ZIF-8 was much superior to 
that of a mixture of GOx@DNA/ZIF-8 and free HRP, HRP@DNA/ZIF-8 and free GOx, and 
GOx@DNA/ZIF-8 and HRP@DNA/ZIF-8 under same protein concentration. The enhanced enzymatic 
activity of GOx&HRP@DNA/ZIF-8 might be due to rapid consumption of the generated intermediate 
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H2O2 due the proximity of the enzymes. Furthermore, DNA scaffold network provides a good platform 
for the uniform distribution of GOx and HRP in close proximity within the framework of ZIF-8. The kinetic 
data revealed that the Km and kcat/Km for GOx&HRP@DNA/ZIF-8 was 13.8 mM and 3.47 s-1mM-1, which 
was 0.27-fold lower and 9.9-fold higher than those of free GOx&HRP, respectively, thus suggesting 
better substrate affinity. In addition, GOx&HRP@DNA/ZIF-8 showed higher stability than the free 
enzymes in reusability tests by exhibiting more than 87% of the initial activity after 14 cycles. 
 
Figure 12. Synthesis and cascade catalytic activity of GOx&HRP@DNA/ZIF-8. Reproduced with 
permission from ref.45 Elsevier, Copyright 2019. 
In another work, a cascade bioreactor was constructed by encapsulating HRP and GOx within 
the pores of ZIF-8 nanostructures (ZIF-8@GOx/HRP) and its catalytic activity was tested in the 
synergistic cancer starvation/oxidation therapy.46  The encapsulated GOx is mainly responsible for the 
depletion of intratumoral glucose by its transformation into gluconic acid causing the inhibition of the 
cancer metabolic pathways. Further, the in-situ formed gluconic acid accelerates the reaction between 
HRP and the formed H2O2. Oxidation therapy is based on the ability of HRP to decompose H2O2 to give 
hydroxyl radical as highly reactive oxygen species that generates oxidative stress in the tumor cells 
causing their death. Interestingly, GOx in ZIF-8@GOx/HRP catalyzed the conversion of glucose to 
gluconic acid and H2O2 (Figure 13A), and further, HRP promotes the oxidation of TMB by the in-situ 
formed H2O2 providing a glucose-concentration-dependent colour change at 652 nm (Figure 13B,C), 
allowing to follow the course of hydroxyl radical production through the cascade reaction. In contrast, 
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the free GOx/HRP only exhibited a weak absorption at 652 nm, which is 2.4-fold lower than the 
absorption of ZIF-8@GOx/HRP at 100 μg/mL. Furthermore, negligible absorption was seen with ZIF-
8@GOx and ZIF-8@HRP solutions, suggesting that neither GOx nor HRP independently can promote 
the cascade reaction. These control experiments clearly imply that the as obtained ZIF-8@GOx/HRP 
could efficiently promote cascade reaction by retaining the enzymatic activities of GOx and HRP and 
also enhances the catalytic activity of encapsulated enzymes compared to free enzymes. The superior 
activity of ZIF-8@GOx/HRP is ascribed to the enhanced stability of enzymes by the rigid structure of 
ZIF-8 as well as their close proximity. In a related theoretical study, it was observed that the small 
distance between enzymes within the confinement zone accelerates the reaction rates and yield by the 
faster reaction of the formed intermediates. In contrast, if the intermediate decay were not fast, the rate 
of cascade reactions would not be altered by the confinement.47 
 
Figure 13. (A) Schematic illustration of cascade catalytic reaction between ZIF-8@GOx/HRP NPs and 
glucose. (B) Absorbance spectra and visual colour changes of TMB oxidization from cascade catalytic 
reaction in six different samples. (C) Glucose-concentration-dependent absorbance spectra of TMB 
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oxidation from cascade catalytic reaction in ZIF-8@GOx/HRP. Reproduced with permission from ref.46 
American Chemical Society, Copyright 2019. 
A magnetic multi-enzyme solid was fabricated through co-precipitation of enzymes and 
HKUST-1 (HKUST: Hong Kong University of Science and Technology) precursors with the aid of 
magnetic Fe3O4 NPs. The spatial co-localization of GOx and HRP enzymes was achieved using a layer-
by-layer positional assembly strategy (Figure 14) and the activity of the resulting solids was tested in 
the cascade oxidation of glucose and o-phenylenediamine.48 Among the various solid catalysts 
employed for this tandem reaction, the use of GOx@HRP@HKUST-1@Fe3O4 solid exhibited superior 
kinetics with a Michaelis constant Km=0.8 mmol L-1 and the maximum reaction rate Vmax= 11.3 µmol L-
1min-1. Furthermore, the enzyme-HKUST-1 hybrid showed remarkably operational stability compared 
to the free enzymes. 
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Figure 14. Schematic illustration of the three different strategies for the positional assembly and spatial 
co-localization of GOx and HRP, and their cascade biocatalysis reaction. DAP: diaminophenazine; 
OPD: o-phenylenediamine. Reproduced with permission from ref.48, Royal Society of Chemistry, 
Copyright 2017 under Creative Common Licence (CC BY-NC 3.0). 
4. Enzyme@MOFs for cancer therapy 
A dual enzyme-functionalized core-shell nanomotor (designated as UTZCG) based on ZIF-8 
MOF NPs was developed for enhancing synergetic photodynamic therapy (PDT) and starvation therapy 
(ST).49 GOx promotes the decomposition of intracellular glucose causing cell starvation and 
simultaneous generation of H2O2. On other hand, catalase-triggered decomposition of both endogenous 
and GOx generated H2O2 fuels the nanomotors, increasing their motion and, even resulting in a higher 
cellular uptake of the therapeutic nanomotors. Meanwhile, the produced oxygen not only promotes 
singlet oxygen generation during near infrared light-triggered PDT process, but also facilitates the GOx-
triggered decomposition of glucose (Figure 15). Overall, this work has demonstrated the possibility to 
apply MOF based enzymatic systems cancer treatment, the mechanism of the therapeutic action being 
based on cascade reactions.  
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Figure 15. Illustration of the fabrication of a UTZCG nanomotor and synergetic photodynamic-starvation 
combined anticancer therapy based on the occurrence of cascade reactions. Reproduced with 
permission from ref.49 Elsevier, Copyright 2019. 
A highly efficient and sensitive electrochemical impedimetric aptasensor was developed for the 
detection of carcinoembryonic antigen by using hybrid solid Pt@CuMOFs-hGq-GOx (Figure 16A) as 
signal transduction probes.50 In this solid catalyst, Pt@CuMOFs was utilized as nanocarriers to 
immobilize Pt NPs, hemin/G-quadruplex (hGq) and GOx. Upon the addition of 3,3-diaminobenzidine 
(DAB) and glucose to the electrode interface modified with Pt@CuMOFs-hGq-GOx, the cascade 
reaction was initiated by the oxidation of glucose by GOx by forming, in situ H2O2. Later, Pt@CuMOFs 
and hGq act as synergistic catalysts promoting the oxidation by H2O2 of DAB to nonconductive insoluble 
precipitates (Figure 16B). These results indicate that the close proximity of Pt@CuMOFs, hGq and GOx 
without having any confinement could also promotes cascade catalysis. These types of results would 
be highly promising for the development of proteins assaying in clinic medicine due to its high sensitivity 
and long term stability. 
 
Figure 16. (A) Preparation process of Pt@CuMOFs-hGq-GOx, (B) Cascade catalysis amplification to 
form nonconductive insoluble precipitates. Reproduced with permission from ref.50 Elsevier, Copyright 
2017. 
5. Conclusions and Future prospects 
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 The commented reports have shown that the synthesis of several MOFs, their composition and 
structure is compatible with enzymes that become embedded inside or strongly adsorbed on the MOF 
crystallites without losing their catalytic activity. In fact, there are several examples that have shown 
that the intrinsic catalytic activity of the enzyme even increases, particularly for cascade reactions, as 
consequence of the association with complementary catalytic sites in close proximity. It is claimed that 
this proximity is a key factor in the enhancement observed of the enzyme-MOF assembly in cascade 
reaction. Furthermore, in addition to increased activity, it appears that the enzyme becomes stabilized 
when it is confined or associated to the MOF. In addition the enzyme-MOF system can be easily 
recovered or immobilized. 
It can be anticipated that the area will expand with additional examples of enzymes, particularly 
those commercially available. It has been shown that the enzyme does not need to be occluded within 
mesopores, but many types of MOF particles can grow around the enzyme, without blocking 
accessibility of substrates and reagents to the enzyme active centre. This possibility expands also 
considerably the type of MOFs that can be used, with the main limitation that the synthesis conditions 
have to be compatible with the enzyme stability. 
Thus, considering that enzyme immobilization has been long pursued as a way to implement 
biocatalysis at commercial level, the available data indicate that MOFs are among the best candidates 
as supports with the additional advantage that MOFs can introduce Lewis acid/base centres and can 
host metal and metal oxide NPs. All these features, together with structural stability, will be exploited in 
the near future to develop cascade reactions, combining two or more elementary reactions in a single 
process.  
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This work describes the recent developments for the integration of enzymes with metal organic 
frameworks as multifunctional solids for cascade (bio)catalysis. 
